Evidence map›Paper›PMID 41328632›Full record

ReviewJournal of comparative effectiveness research2026

Evaluating the feasibility of a network meta-analysis comparing treatment options in polycythemia vera.

Paul Walden, Noemi Hummel, Agnieszka Kopiec, Zuzanna Maliszewska, Emi Naslazi

Abstract readReviewNetwork Meta-Analysis
In one paragraph

Review in Journal of comparative effectiveness research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paul WaldenPharmaEssentia, Burlington, MA, USA.
Noemi HummelCertara GmbH, Lörrach, Germany.ORCID 0009-0000-5656-5025
Agnieszka KopiecCertara, Krakow, Poland.
Zuzanna MaliszewskaCertara, Krakow, Poland.
Emi NaslaziCertara, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Polycythemia VeraFeasibility StudiesHumansHydroxyureaInterferon-alphaInterferon alpha-2NitrilesPolyethylene GlycolsPyrazolesPyrimidinesRecombinant ProteinsHydroxyureaInterferon-alphaInterferon alpha-2Nitrilespeginterferon alfa-2apeginterferon alfa-2bPolyethylene GlycolsPyrazolesPyrimidinesRecombinant Proteinsruxolitinibindirect treatment comparisonnetwork meta-analysispolycythemia veraropeginterferon alfa-2b-njft

Identifiers

PMID41328632
PMCPMC12711096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.